Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Treatment with metformin as monotherapy prior to eligibility assessment that has failed to result in adequate glycemic control at the discretion of the investigator or treatment provider. However, prior short-term treatment with an oral glucose lowering agent or insulin for up to 14 consecutive days in addition to metformin is allowed if discontinued prior to screening.
Current member of a health plan which includes pharmacy benefits.
HbA1c greater than or equal to 7% within last 90 days prior to the day of screening or to be taken before randomization.
Further intensification with an additional glucose-lowering oral agent including oral semaglutide is indicated according to approved prescribing information to achieve glycemic target at the discretion of the treatment provider.
You may not be if
Female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using contraception.
Any disorder which in the investigator's or treatment provider's opinion might jeopardize patient's safety.
